Ascorbic acid is neuroprotective against global ischaemia in striatum but not hippocampus: Histological and voltammetric data

Brain Research

Volumn 835, Issue 2, 1999, Pages 229-240

  Stamford, Jonathan A ^a   Isaac, Dina ^a   Hicks, Caroline A ^b   Ward, Mark A ^b   Osborne, David J ^b   O'Neill, Michael J ^b  

^a Acad Dept Anaesthesia Intensive C   (United Kingdom)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

Ascorbic acid; Dopamine; Gerbil; Global ischaemia; Hippocampus; Neuroprotection; Rat; Striatum

Indexed keywords

ASCORBIC ACID; DOPAMINE; EOSIN; HEMATOXYLIN; N ETHYLMALEIMIDE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; BRAIN SLICE; CELL LOSS; CONTROLLED STUDY; CORPUS STRIATUM; GERBIL; HIPPOCAMPUS; HISTOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NEUROPROTECTION; NONHUMAN; POTENTIOMETRY; PRIORITY JOURNAL; RAT;

ALKYLATING AGENTS; ANIMALS; ASCORBIC ACID; BRAIN ISCHEMIA; CORPUS STRIATUM; DOPAMINE; DRUG INTERACTIONS; ELECTROCHEMISTRY; ETHYLMALEIMIDE; GERBILLINAE; HIPPOCAMPUS; MALE; N-METHYLASPARTATE; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS; RATS; RATS, WISTAR;

EID: 0033600499     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01587-5     Document Type: Article

References (71)

1. Aizenman E., Lipton S.A., Loring R.H. Selective modulation of NMDA responses by reduction and oxidation. Neuron. 2:1989;1257-1263.
2. 3H -ADTN to calf caudate membranes Neuropharmacology. 21:1982;601-604.
3. Armstrong-James M., Millar J. Carbon fibre microelectrodes. J. Neurosci. Methods. 1:1979;279-287.
4. Bell J.A., Beglan C.L., London E.D. Interaction of ascorbic acid with the neurotoxic effects of NMDA and sodium nitroprusside. Life Sci. 58:1995;367-371.
5. Beyer R.E. The role of ascorbate in antioxidant protection of biomembranes: interaction with vitamin E and coenzyme. Q.J. Bioenerg. Biomembr. 26:1994;349-358.
6. Block F., Schmitt W., Schwarz M. The antioxidant LY 231617 ameliorates functional and morphological sequelae induced by global ischaemia in rats. Brain Res. 694:1995;308-311.
7. Block F., Schmitt W., Schwarz M. Pretreatment but not posttreatment with GYKI 52466 reduces functional deficits and neuronal damage after global ischemia in rats. J. Neurol. Sci. 139:1996;167-172.
8. Brazell M.P., Marsden C.A. Intracerebral injection of ascorbate oxidase - effect on in vivo electrochemical recordings. Brain Res. 249:1982;167-172.
9. Brown A.W., Brierley J.B. The nature, distribution and earliest stages of anoxic-ischaemic nerve cell damage in the rat brain as defined by the optical microscope. Br. J. Exp. Pathol. 49:1968;87-106.
10. Buettner G.R., Jurkiewicz B.A. Catalytic metals, ascorbate and free radicals: combinations to avoid. Radiat. Res. 145:1996;532-541.
11. Buisson A., Callebert J., Mathieu E., Plotkine M., Boulu R.G. Striatal protection induced by lesioning the substantia nigra of rats subjected to focal ischaemia. J. Neurochem. 59:1992;1153-1157.
12. Cammack J., Ghasemzadeh B., Adams R.N. The pharmacological profile of glutamate-evoked ascorbic acid efflux measured by in vivo electrochemistry. Brain Res. 565:1991;17-22.
13. Clemens J.A., Phebus L.A. Dopamine depletion protects striatal neurons from ischaemia-induced cell death. Life Sci. 42:1988;707-713.
14. Cooper A.J., Pulsinelli W.A., Duffy T.E. Glutathione and ascorbate during ischemia and postischemic reperfusion in rat brain. J. Neurochem. 35:1980;1242-1245.
15. Crespi F. Concomitant in vivo electrophysiological and voltammetric analysis indicate that ascorbic acid is a biochemical index of early ischaemia. Neurosci. Lett. 215:1996;189-192.
16. 3H )PN200-110 to membranes from rat brain and heart by ascorbate is mediated by lipid peroxidation J. Pharm. Exp. Ther. 259:1991;337-344.
17. Ewing A.G., Wightman R.M., Dayton M.A. In vivo voltammetry with electrodes that discriminate between dopamine and ascorbate. Brain Res. 249:1982;361-370.
18. Girbe F., Ramassamy C., Piton C., Costentin J. Ascorbic acid increases synaptosomal potassium-induced dopamine release. Neuroreport. 5:1994;1027-1029.
19. Globus M.Y., Busto R., Dietrich W.D., Martinez E., Valdes I., Ginsberg M.D. Intra-ischemic extracellular release of dopamine and glutamate is associated with striatal vulnerability to ischemia. Neurosci. Lett. 91:1988;36-40.
20. Globus M.Y., Ginsberg M.D., Busto R. Excitotoxic index - a biochemical marker of selective vulnerability. Neurosci. Lett. 127:1991;39-42.
21. Globus M.Y., Ginsberg M.D., Dietrich W.D., Busto R., Scheinberg P. Substantia nigra lesion protects against ischemic damage in the striatum. Neurosci Lett. 80:1987;251-256.
22. Grunewald R.A., Fillenz M. Release of ascorbate from a synaptosomal fraction of rat brain. Neurochem. Int. 6:1984;491-500.
23. Halliwell B. Oxidants and the central nervous system: some fundamental questions Is oxidant damage relevant to Parkinson's disease, Alzheimer's disease, traumatic injury or stroke? Acta Neurol. Scand. 126:1989;23-33. Suppl.
24. Hanck A. Tolerance and effects of high doses of ascorbic acid. Dosis facit venenum. Int. J. Vitam. Nutr. Res. Suppl. 23:1982;221-238.
25. Hashimoto N., Matsumoto T., Mabe H., Hashitani T., Nishino H. Dopamine has inhibitory and accelerating effects on ischaemia - induced neuronal cell damage in the rat striatum. Brain Res. Bull. 33:1994;281-288.
26. Hastings T.G., Lewis D.A., Zigmond M.J. Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections. Proc. Natl. Acad. Sci. USA. 93:1996;1956-1961.
27. 3H )dopamine: impact of ascorbic acid and glutathione J. Neurochem. 63:1994;1126-1132.
28. 3H )dopamine antagonists to neostriatal membrane preparations: relationship to lipid peroxidation J. Neurochem. 38:1982;1000-1006.
29. Kuo C.H., Yonehara N., Hata F., Yoshida H. Subcellular distribution of ascorbic acid in rat brain. Jpn. J. Pharmacol. 28:1978;789-791.
30. Lancelot E., Callebert J., Plotkine M., Boulu R.G. Striatal dopamine participates in glutamate-induced hydroxyl radical generation. Neuroreport. 6:1995;1033-1036.
31. Landolt H., Lutz T.W., Langemann H., Stauble D., Mendelowitsch A., Gratzl O., Honegger C.G. Extracellular antioxidants and amino acids in the cortex of the rat: monitoring by microdialysis of early ischemic changes. J. Cereb. Blood. Flow. Metab. 12:1992;96-102.
32. Lekieffre D., Meldrum B.S. The pyrimidine-derivative, BW1003C87, protects CA1 and striatal neurons following transient severe forebrain ischaemia in rats. A microdialysis and histological study. Neuroscience. 56:1993;93-99.
33. MacGregor D.G., Higgins M.J., Jones P.A., Maxwell W.L., Watson M.W., Graham D.I., Stone T.W. Ascorbate attenuates the systemic kainate-induced neurotoxicity in the rat hippocampus. Brain Res. 727:1996;133-144.
34. Majewska M.D., Bell J.A., London E.D. Regulation of the NMDA receptor by redox phenomena: inhibitory role of ascorbate. Brain Res. 537:1990;328-332.
35. McIlwain H., Thomas J., Bell J.L. The composition of isolated cerebral tissues: ascorbic acid and cozymase. Biochem. J. 64:1956;332-335.
36. Miele M., Boutelle M.G., Fillenz M. The physiologically induced release of ascorbate in rat brain is dependent on impulse traffic, calcium influx and glutamate uptake. Neuroscience. 62:1994;87-91.
37. Milby K., Oke A., Adams R.N. Detailed mapping of ascorbate distribution in rat brain. Neurosci. Lett. 28:1982;15-20.
38. O'Neill M.J., Hicks C., Ward M. Neuroprotective effects of 7-nitroindazole in the gerbil model of global cerebral ischaemia. Eur. J. Pharmacol. 310:1996;15-22.
39. Paxinos, G., Watson, C., The Rat Brain in Stereotaxic Coordinates, Academic Press, London, 1986.
40. Phebus L.A., Perry K.W., Clemens J.A., Fuller R.W. Brain anoxia releases striatal dopamine in rats. Life Sci. 38:1986;2447-2453.
41. Pulsinelli W.A., Brierley J.B., Plum F. Temporal profile of neuronal damage in a model of transient forebrain ischaemia. Ann. Neurol. 11:1982;491-498.
42. Ranjan A., Theodore D., Haran R.P., Chandy M.J. Ascorbic acid and focal cerebral ischaemia in a primate model. Acta Neurochir. (Wien). 123:1993;87-91.
43. Rebec G.V., Centore J.M., White L.K., Alloway K.D. Ascorbic acid and the behavioral response to haloperidol: implications for the action of antipsychotic drugs. Science. 227:1985;438-440.
44. Rees D.C., Kelsey H., Richards J.D.M. Acute haemolysis induced by high dose ascorbic acid in glucose-6-phosphate dehydrogenase deficiency. Br. Med. J. 306:1993;841-842.
45. 2+ fluxes Br. J. Pharmacol. 101:1990;178-182.
46. Rice M.E., Cammack J. Anoxia-resistant turtle brain maintains ascorbic acid content in vitro. Neurosci. Lett. 132:1991;141-145.
47. Rice M.E., Perez-Pinzon M.A., Lee E.J. Ascorbic acid, but not glutathione, is taken up by brain slices and preserves cell morphology. J. Neurophysiol. 71:1994;1591-1596.
48. Richards C.D., Tegg W.J.B. A superfusion chamber suitable for maintaining mammalian brain tissue slices for electrical recording. Br. J. Pharmacol. 59:1977;526P.
49. Sato P.H., Hall E.D. Tirilazad mesylate protects vitamins C and E in brain ischemia-reperfusion injury. J. Neurochem. 58:1992;2263-2268.
50. Sharma S.K., Johnstone R.M., Quastel J.H. Active transport of ascorbic acid in adrenal cortex and brain cortex in vitro and the effects of ACTH and steroids. Can. J. Biochem. Physiol. 41:1963;597-604.
51. Shimizu N., Matsunami T., Onishi S. Histochemical demonstration of ascorbic acid in the locus coeruleus of the mammalian brain. Nature. 186:1960;479-480.
52. Spector R. Penetration of ascorbic acid from cerebrospinal fluid into brain. Exp. Neurol. 72:1981;645-653.
53. Spector R., Lorenzo A.V. Ascorbic acid homeostasis in the central nervous system. Am. J. Physiol. 225:1973;757-763.
54. Stamford J.A. Effect of electrocatalytic and nucleophilic reactions on fast voltammetric measurements of dopamine at carbon fiber microelectrodes. Anal. Chem. 58:1986;1033-1036.
55. Stamford J.A., Kruk Z.L., Millar J. Regional differences in extracellular ascorbic acid levels in the rat brain determined by high speed cyclic voltammetry. Brain Res. 299:1984;289-295.
56. Stamford J.A., Kruk Z.L., Millar J. Ascorbic acid does not modulate stimulated dopamine release: in vivo voltammetric data in the rat. Neurosci. Lett. 60:1985;357-362.
57. Subramanian N. On the brain ascorbic acid and its importance in metabolism of biogenic amines. Life Sci. 20:1977;1479-1484.
58. Suzuki J., Fujimoto S., Mizoi K., Oba M. The protective effect of combined administration of anti-oxidants and perfluorochemicals on cerebral ischemia. Stroke. 15:1984;672-679.
59. 2+ exchanger in cultured rat astrocytes. J. Neurochem. 64:1995;1536-1540.
60. Tauck D.L. Redox modulation of NMDA receptor-mediated synaptic activity in the hippocampus. Neuroreport. 3:1992;781-784.
61. Tolbert L.C., Thomas T.N., Middaugh L.D., Zemp J.W. Ascorbate blocks amphetamine-induced turning behavior in rats with unilateral nigro-striatal lesions. Brain Res. Bull. 4:1979;43-48.
62. Toner C.C., Stamford J.A. Effects of anaesthetic drugs on dopamine release in a model of hypoxia and hypoglycaemia. Br. J. Anaesth. 75:1995;660P.
63. Toner C.C., Stamford J.A. Real time measurement of dopamine release in an in vitro model of neostriatal ischaemia. J. Neurosci. Methods. 67:1996;133-140.
64. Toner C.C., Stamford J.A. Involvement of N- and P/Q- but not L- or T-type voltage-gated calcium channels in ischaemia-induced striatal dopamine release in vitro. Brain Res. 748:1997;85-92.
65. Toner C.C., Stamford J.A. Sodium channel blockade unmasks two temporally distinct mechanisms of striatal dopamine release during hypoxia/hypoglycaemia in vitro. Neuroscience. 81:1997;999-1007.
66. Toner C.C., Stamford J.A. Characteristics of the NMDA receptor modulating hypoxia/hypoglycaemia-induced rat striatal dopamine release in vitro. Eur. J. Pharmacol. 340:1997;133-143.
67. Traystman R.J., Kirsch J.R., Koehler R.C. Oxygen radical mechanisms of brain injury following ischemia and reperfusion. J. Appl. Physiol. 71:1991;1185-1195.
68. Volterra A., Trotti D., Racagni G. Glutamate uptake is inhibited by arachidonic acid and oxygen radicals via two distinct and additive mechanisms. Mol. Pharmacol. 46:1994;986-992.
69. Walker M.C., Galley P.T., Errington M.L., Shorvon S.D., Jefferys J.G. Ascorbate and glutamate release in the rat hippocampus after perforant path stimulation: a "dialysis electrode" study. J. Neurochem. 65:1995;725-731.
70. Weinberger J., Nieves-Rosa J., Cohen G. Nerve terminal damage in cerebral ischaemia: protective effect of alpha-methyl-para-tyrosine. Stroke. 16:1985;864-870.
71. Wolf-Heidegger G. Histochemische untersuchungen zum nachweis und zur lokalisation des Vitamin C in zentralnervensystem. Confinia Neurol. 4:1942;121-147.